|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9120 USD | -0.22% |
|
+0.44% | -0.44% |
| 01-08 | BIOPHARMA CREDIT PLC Appoints Nigel Hugh Reynolds as Director, Effective January 1, 2026 | CI |
| 12-30 | BioPharma Credit receives funds from loan prepayment | AN |
| Capitalization | 1.03B 892M 830M 773M 1.44B 93.85B 1.55B 9.55B 3.77B 44.77B 3.88B 3.8B 163B | P/E ratio 2023 |
10.1x | P/E ratio 2024 | 8.84x |
|---|---|---|---|---|---|
| Enterprise value | 1.03B 887M 826M 769M 1.43B 93.34B 1.54B 9.5B 3.74B 44.52B 3.86B 3.78B 163B | EV / Sales 2023 |
7.07x | EV / Sales 2024 | 6.96x |
| Free-Float |
83.82% | Yield 2023 |
8.33% | Yield 2024 | 7.92% |
More valuation ratios
* Estimated data
More news
| 22/09/25 | BioPharma Credit : Half Year Report | PU |
| 24/09/24 | BioPharma Credit : Half-year Report | PU |
| 13/06/24 | BioPharma Credit : Resolutions passed at AGM | PU |
| 28/12/23 | BioPharma Credit : Resolution passed at General Meeting | PU |
| 19/06/20 | BioPharma Credit : Change of AGM Venue | PU |
| 1 day | -0.22% | ||
| 1 week | +0.44% | ||
| Current month | -0.44% | ||
| 1 month | +0.22% | ||
| 3 months | -0.44% | ||
| 6 months | +3.40% | ||
| Current year | -0.44% |
| 1 week | 0.9 |  | 0.92 |
| 1 month | 0.9 | | 0.93 |
| Current year | 0.9 | | 0.93 |
| 1 year | 0.8 | | 0.98 |
| 3 years | 0.8 | | 0.98 |
| 5 years | 0.8 | | 1.05 |
| 10 years | 0.7 | | 1.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Investment Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Duncan Budge
BRD | Director/Board Member | 70 | 15/09/2020 |
| Director/Board Member | 66 | 31/10/2016 | |
Harry Hyman
CHM | Chairman | 69 | 15/09/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.22% | +0.44% | +7.04% | -4.40% | 1.03B | |
| -2.94% | +11.12% | +188.70% | +260.61% | 18.06B | |
| -0.43% | +1.80% | +67.85% | +136.85% | 16.66B | |
| -2.19% | -0.64% | +9.84% | +54.80% | 10.97B | |
| -1.70% | +5.57% | +106.70% | +178.65% | 9.98B | |
| +0.06% | -0.38% | -4.58% | -9.49% | 6.86B | |
| +0.23% | +8.88% | +23.75% | +87.90% | 6.77B | |
| -1.56% | +0.26% | +19.75% | +11.14% | 4.68B | |
| -1.02% | -0.41% | -34.82% | -23.55% | 4.06B | |
| +0.50% | +0.80% | +7.03% | -13.66% | 3.72B | |
| Average | -0.93% | +2.74% | +39.13% | +67.89% | 8.28B | |
| Weighted average by Cap. | -1.32% | +4.10% | +70.35% | +118.39% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 136M 117M 109M 101M 189M 12.32B 203M 1.25B 494M 5.87B 509M 499M 21.45B | 150M 129M 120M 112M 209M 13.61B 225M 1.39B 546M 6.49B 563M 551M 23.71B |
| Net income | 108M 93.49M 87.04M 81.03M 151M 9.84B 162M 1B 395M 4.69B 407M 398M 17.14B | 122M 105M 98.05M 91.28M 170M 11.09B 183M 1.13B 445M 5.29B 458M 449M 19.31B |
| Net Debt | -135M -116M -108M -101M -188M -12.25B -202M -1.25B -492M -5.85B -506M -496M -21.34B | -5.62M -4.85M -4.51M -4.2M -7.82M -510M -8.41M -51.88M -20.46M -243M -21.08M -20.64M -888M |
More financial data
* Estimated data
Employees
-
Sector
Closed End Funds
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 0.9120 $ | -0.22% | 1,274,912 |
| 15/01/26 | 0.9140 $ | +1.33% | 1,389,293 |
| 14/01/26 | 0.9020 $ | -0.66% | 2,445,490 |
| 13/01/26 | 0.9080 $ | 0.00% | 1,958,707 |
| 12/01/26 | 0.9080 $ | 0.00% | 765,435 |
Delayed Quote London S.E., January 16, 2026 at 04:35 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.9120
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- BPCP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition